$5,000 invested in CSL shares 12 months ago is now worth…

MotleyFool03-25 10:31

CSL Ltd (ASX: CSL) shares are in the green in Wednesday lunchtime trade. At the time of writing, the shares are up 1.2% to $141 a piece. In fact, over the past five days, the biotech company's stock ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2622043678?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-25 10:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622043678","market":"hk","top_or_hot":-1,"title":"$5,000 invested in CSL shares 12 months ago is now worth…","media":"MotleyFool","content":"<div>\n<p>CSL Ltd (ASX: CSL) shares are in the green in Wednesday lunchtime trade. At the time of writing, the shares are up 1.2% to $141 a piece. In fact, over the past five days, the biotech company's stock ...</p>\n\n<a href=\"https://www.fool.com.au/2026/03/25/5000-invested-in-csl-shares-12-months-ago-is-now-worth/\">Source Link</a>\n\n</div>\n","source":"motleyfoolau_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>$5,000 invested in CSL shares 12 months ago is now worth…</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n$5,000 invested in CSL shares 12 months ago is now worth…\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-25 10:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com.au/2026/03/25/5000-invested-in-csl-shares-12-months-ago-is-now-worth/><strong>MotleyFool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>CSL Ltd (ASX: CSL) shares are in the green in Wednesday lunchtime trade. At the time of writing, the shares are up 1.2% to $141 a piece. In fact, over the past five days, the biotech company's stock ...</p>\n\n<a href=\"https://www.fool.com.au/2026/03/25/5000-invested-in-csl-shares-12-months-ago-is-now-worth/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CSL","symbol_name":"卡莱尔伙伴","start_time":0,"source_url":"https://www.fool.com.au/2026/03/25/5000-invested-in-csl-shares-12-months-ago-is-now-worth/","article_id":"2622043678","we_media_id":null,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/25/5000-invested-in-csl-shares-12-months-ago-is-now-worth/","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2622043678","pubTimestamp":1774405911,"columns":[],"sourceInfo":{"source_id":"motleyfoolau_stock","name":"MotleyFool"},"weMediaInfo":null,"summary":"CSL Ltd  shares are in the green in Wednesday lunchtime trade. At the time of writing, the shares are up 1.2% to $141 a piece. In fact, over the past five days, the biotech company's stock price has continually climbed, now up 4%.It's great news for investors, as the beaten-down stock's share price has crashed significantly over the past 18 months. Several headwinds, including lacklustre financial results, a surprise restructure announcement, a shock CEO exit and revised revenue guidance, all helped push the share price down.Concerns around margins and broad market conditions haven't helped the biotech company's shares either. Healthcare stocks have lagged in 2026 as investors shift towards the resources and energy sectors.At the time of writing, the S&P/ASX 200 Health Care Index  is down 5% over the past month and 17.5% for the year-to-date.For context, the S&P/ASX 200 Index  is down 5.2% over the past month and 1.8% year-to-date.Meanwhile, $5,000 invested in the company's shares when","collect":0,"end_time":0,"defaultTopTitle":"fool.com.au","property":[],"viewcount":null,"language":"en","relate_stocks":{"CSL":"卡莱尔伙伴","BK4086":"建筑产品","LU1169590202.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"I\" (USD) ACC","LU0728928796.USD":"abrdn SICAV I - GLOBAL SMALL&MID-CAP SDG HORIZONS EQUITY \"A\" (USD) ACC","SG9999004303.SGD":"Nikko AM Shenton Global Opportunities SGD","SGXZ23171101.USD":"NIKKO AM SHENTON GLOBAL OPPORTUNITIES (USD) ACC","LU1169589451.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"A\" (USD) ACC","BK7067":"生物科技","BK7508":"医药生物股","BK7511":"ESG概念","BK7501":"新冠治疗股","XJO.AU":"标普/澳交所 200指数","CSL.AU":"CSL LIMITED"},"translate_title":"12个月前投资CSL股票的5,000美元现在价值……","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XJO.AU":1,"CSL":1.5,"CSL.AU":1.5},"content_text":"CSL Ltd (ASX: CSL) shares are in the green in Wednesday lunchtime trade. At the time of writing, the shares are up 1.2% to $141 a piece. In fact, over the past five days, the biotech company's stock price has continually climbed, now up 4%.\nIt's great news for investors, as the beaten-down stock's share price has crashed significantly over the past 18 months. Several headwinds, including lacklustre financial results, a surprise restructure announcement, a shock CEO exit and revised revenue guidance, all helped push the share price down.\nConcerns around margins and broad market conditions haven't helped the biotech company's shares either. Healthcare stocks have lagged in 2026 as investors shift towards the resources and energy sectors. \nAt the time of writing, the S&P/ASX 200 Health Care Index (ASX: XHJ) is down 5% over the past month and 17.5% for the year-to-date.\nFor context, the S&P/ASX 200 Index (ASX: XJO) is down 5.2% over the past month and 1.8% year-to-date.\nImage source: Getty Images\nIf I bought $5,000 worth of CSL shares 12 months ago, what are they worth now?\nThe company's share price is down 18% year-to-date and 45% over the past 12 months.\nToday's share price uptick means that $5,000 invested in the biotech company 12 months ago is now worth just $2,750.\nMeanwhile, $5,000 invested in the company's shares when the ASX first opened for the year on the 2nd of January is now worth $4,100.\nBut it's not all doom and gloom for CSL shares\nCSL is an Australian-based biotech company that develops biotherapies and vaccines, and plasma-derived medicines are at the core of its business. The company's blood plasma division is a frontrunner in the market for rare blood disorders and immunoglobulin products. And demand is booming.\nBuilding demand for plasma therapies in a market with limited competition means CSL's business is likely to experience strong growth.\nThe company itself is robust, too. CSL has experienced periods of double-digit growth, and its positive forecast implies a long-term recovery is ahead.\nAnalysts are also very bullish on CSL's outlook. Many think the sell-off was way overdone and that the company is now trading at below fair value.\nTradingView data shows that 12 out of 18 analysts currently have a buy or strong buy rating on the stock. The average target price is $209.50, which implies a 50% upside at the time of writing. However, some think the share price could storm even higher, by 94% to $272.53 a piece.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2622043678","isCrawlerRequest":true}